Gengos Andrew (CIK 1563623) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-01-16). Recent activity: Buy TERN (68,750 shares), Buy TTRX (10,000 shares), Buy TERN (5,000 shares), Buy TERN (5,000 shares), Buy TERN (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | Buy | 68,750 | $0 |
| 2025-10-10 | Turn Therapeutics Inc. (TTRX) | Director | Buy | 10,000 | $0 |
| 2025-06-30 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | Buy | 5,000 | $19,650 |
| 2025-06-30 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | Buy | 5,000 | $19,650 |
| 2025-06-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | Buy | 5,000 | $18,750 |
| 2025-06-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | Buy | 5,000 | $18,600 |
| 2025-06-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | Buy | 5,000 | $19,750 |
Source: SEC Form 4 filings · as of 2026-01-16